140 related articles for article (PubMed ID: 26420977)
1. Corticosteroid and nucleoside analogue for hepatitis B virus-related acute liver failure.
Fujiwara K; Yasui S; Yokosuka O
World J Gastroenterol; 2015 Sep; 21(36):10485-6. PubMed ID: 26420977
[TBL] [Abstract][Full Text] [Related]
2. Combined glucocorticoid and antiviral therapy of hepatitis B virus-related liver failure.
Bockmann JH; Dandri M; Lüth S; Pannicke N; Lohse AW
World J Gastroenterol; 2015 Feb; 21(7):2214-9. PubMed ID: 25717260
[TBL] [Abstract][Full Text] [Related]
3. The requirement for a sufficient period of corticosteroid treatment in combination with nucleoside analogue for severe acute exacerbation of chronic hepatitis B.
Fujiwara K; Yasui S; Okitsu K; Yonemitsu Y; Oda S; Yokosuka O
J Gastroenterol; 2010 Dec; 45(12):1255-62. PubMed ID: 20614156
[TBL] [Abstract][Full Text] [Related]
4. Early Combination Therapy with Corticosteroid and Nucleoside Analogue Induces Rapid Resolution of Inflammation in Acute Liver Failure due to Transient Hepatitis B Virus Infection.
Fujiwara K; Yasui S; Haga Y; Nakamura M; Yonemitsu Y; Arai M; Kanda T; Oda S; Yokosuka O; Kato N
Intern Med; 2018 Jun; 57(11):1543-1552. PubMed ID: 29321429
[TBL] [Abstract][Full Text] [Related]
5. Virological efficacy of combination therapy with corticosteroid and nucleoside analogue for severe acute exacerbation of chronic hepatitis B.
Yasui S; Fujiwara K; Nakamura M; Miyamura T; Yonemitsu Y; Mikata R; Arai M; Kanda T; Imazeki F; Oda S; Yokosuka O
J Viral Hepat; 2015 Feb; 22(2):94-102. PubMed ID: 24750410
[TBL] [Abstract][Full Text] [Related]
6. Potent antiviral therapy improves survival in acute on chronic liver failure due to hepatitis B virus reactivation.
Philips CA; Sarin SK
World J Gastroenterol; 2014 Nov; 20(43):16037-52. PubMed ID: 25473156
[TBL] [Abstract][Full Text] [Related]
7. Favorable effect of corticosteroids in treating acute-on-chronic liver failure underlying chronic hepatitis B.
Kim H; Kwon JH; Kim YH; Nam SW; Lee JY; Jang JW
Clin Mol Hepatol; 2018 Dec; 24(4):430-435. PubMed ID: 29172397
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of combination therapy of antiviral and immunosuppressive drugs for the treatment of severe acute exacerbation of chronic hepatitis B.
Fujiwara K; Yasui S; Yonemitsu Y; Fukai K; Arai M; Imazeki F; Suzuki A; Suzuki H; Sadahiro T; Oda S; Yokosuka O
J Gastroenterol; 2008; 43(9):711-9. PubMed ID: 18807133
[TBL] [Abstract][Full Text] [Related]
9. Proper antiviral therapy for hepatitis B virus-associated acute-on-chronic liver failure.
Liu T; Zhang C; Wang Y
Hepatology; 2011 Aug; 54(2):747-8. PubMed ID: 21360719
[No Abstract] [Full Text] [Related]
10. Entecavir vs. lamivudine in chronic hepatitis B patients with severe acute exacerbation and hepatic decompensation.
Chen CH; Lin CL; Hu TH; Hung CH; Tseng PL; Wang JH; Chang JY; Lu SN; Chien RN; Lee CM
J Hepatol; 2014 Jun; 60(6):1127-34. PubMed ID: 24583247
[TBL] [Abstract][Full Text] [Related]
11. Initial combination anti-viral therapy with lamivudine and adefovir dipivoxil decreases short-term fatality rate of hepatitis-B-virus-related acute-on-chronic liver failure.
Yang J; Chen G; Chen X; Zhang H; Jiang D; Yang G
Virol J; 2015 Jun; 12():97. PubMed ID: 26104153
[TBL] [Abstract][Full Text] [Related]
12. Outcome of patients suffering from a spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure and treated with antivirals.
Dai CY; Yeh ML; Huang CF; Huang JF; Yu ML; Chuang WL
Hepatology; 2011 Sep; 54(3):1108-9. PubMed ID: 21452286
[No Abstract] [Full Text] [Related]
13. Importance of adequate immunosuppressive therapy for the recovery of patients with "life-threatening" severe exacerbation of chronic hepatitis B.
Fujiwara K; Yokosuka O; Kojima H; Kanda T; Saisho H; Hirasawa H; Suzuki H
World J Gastroenterol; 2005 Feb; 11(8):1109-14. PubMed ID: 15754390
[TBL] [Abstract][Full Text] [Related]
14. Static and dynamic prognostic factors for hepatitis-B-related acute-on-chronic liver failure.
Ha JM; Sohn W; Cho JY; Pyo JH; Choi K; Sinn DH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC; Paik YH
Clin Mol Hepatol; 2015 Sep; 21(3):232-41. PubMed ID: 26523268
[TBL] [Abstract][Full Text] [Related]
15. Antiviral therapy for acute-on-chronic liver failure in chronic hepatitis B: is it too late?
Chan HL
Dig Dis Sci; 2010 Aug; 55(8):2126-8. PubMed ID: 20458619
[No Abstract] [Full Text] [Related]
16. The pros and cons of lamivudine vs. entecavir in decompensated or severe acute exacerbation of chronic hepatitis B.
Shouval D
J Hepatol; 2014 Jun; 60(6):1108-9. PubMed ID: 24636833
[No Abstract] [Full Text] [Related]
17. Acute-on-chronic liver failure in chronic hepatitis B: an update.
Zhao RH; Shi Y; Zhao H; Wu W; Sheng JF
Expert Rev Gastroenterol Hepatol; 2018 Apr; 12(4):341-350. PubMed ID: 29334786
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Lamivudine Versus Entecavir for Treating Chronic Hepatitis B Virus-related Acute Exacerbation and Acute-on-Chronic Liver Failure: A Systematic Review and Meta-Analysis.
Huang KW; Tam KW; Luo JC; Kuan YC
J Clin Gastroenterol; 2017 Jul; 51(6):539-547. PubMed ID: 28067752
[TBL] [Abstract][Full Text] [Related]
19. Management of acute hepatitis B and reactivation of hepatitis B.
Jindal A; Kumar M; Sarin SK
Liver Int; 2013 Feb; 33 Suppl 1():164-75. PubMed ID: 23286861
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid versus traditional therapy for hepatitis B virus-related acute-on-chronic liver failure: A systematic review and meta-analysis.
Gao R; Li Y; Cao Y; Zheng R; Tang L; Yang J; Lu X
Medicine (Baltimore); 2020 Jun; 99(25):e20604. PubMed ID: 32569189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
